标题
Comprehensive Guidance for Antibiotic Dosing in Obese Adults
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 37, Issue 11, Pages 1415-1431
出版商
Wiley
发表日期
2017-09-04
DOI
10.1002/phar.2023
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients
- (2017) William J. Peppard et al. Surgical Infections
- Population Pharmacokinetics and Pharmacodynamics of Doripenem in Obese, Hospitalized Patients
- (2016) Eun Kyoung Chung et al. ANNALS OF PHARMACOTHERAPY
- Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients
- (2016) Abdulaziz S. Alobaid et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Tedizolid in Morbidly Obese and Covariate-Matched Nonobese Adults
- (2016) Manjunath P. Pai ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anti-infective Dosing for Obese Adult Patients: A Focus on Newer Drugs to Treat Methicillin-resistant Staphylococcus aureus Acute Bacterial Skin and Skin Structure Infections
- (2016) Manjunath P. Pai CLINICAL THERAPEUTICS
- 698
- (2016) Shelby Shemanski et al. CRITICAL CARE MEDICINE
- Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review
- (2016) Abdulaziz S. Alobaid et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients
- (2016) Claire Roger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients
- (2016) Eun Kyoung Chung et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-ProducingKlebsiella pneumoniaeBacteremia and Renal Impairment
- (2016) John J. Veillette et al. PHARMACOTHERAPY
- Performance of a Divided-Load Intravenous Vancomycin Dosing Strategy for Obese Patients
- (2015) Tina Harrach Denetclaw et al. ANNALS OF PHARMACOTHERAPY
- Population Pharmacokinetic Analysis for a Single 1,200-Milligram Dose of Oritavancin Using Data from Two Pivotal Phase 3 Clinical Trials
- (2015) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Ceftaroline in Normal Body Weight and Obese (Classes I, II, and III) Healthy Adult Subjects
- (2015) Julie Ann Justo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
- (2015) Ilias Karaiskos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
- (2015) Michael W. Dunne et al. CLINICAL INFECTIOUS DISEASES
- Dosing of antifungal agents in obese people
- (2015) Kenna D. Payne et al. Expert Review of Anti-Infective Therapy
- An Update on the arsenal for multidrug-resistant Acinetobacter infections: Polymyxin antibiotics
- (2015) Zahra Kassamali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients
- (2015) Jason A. Roberts et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
- (2015) Abdulaziz S. Alobaid et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients
- (2015) Eun Kyoung Chung et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The association of elevated trough serum vancomycin concentrations with obesity
- (2015) Janice Richardson et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients
- (2015) Haley J. Morrill et al. PHARMACOTHERAPY
- Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or ConfirmedStaphylococcus aureusInfections
- (2015) Eyob D. Adane et al. PHARMACOTHERAPY
- Individualized Vancomycin Dosing in Obese Patients: A Two-Sample Measurement Approach Improves Target Attainment
- (2015) Joseph Hong et al. PHARMACOTHERAPY
- Creatinine or cystatin C – which is a better index of renal function in morbid obesity?
- (2014) P Mysliwiec et al. Advances in Medical Sciences
- Comparative Pharmacokinetics and Pharmacodynamics of Doripenem and Meropenem in Obese Patients
- (2014) Michael B. Kays et al. ANNALS OF PHARMACOTHERAPY
- Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring
- (2014) Manjunath P. Pai et al. CLINICAL PHARMACOKINETICS
- Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance
- (2014) Jeffrey M. Rybak et al. PHARMACOTHERAPY
- Ceftaroline Fosamil for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Obese Patients
- (2014) John D. Evans et al. POSTGRADUATE MEDICINE
- Broad-spectrum β-lactams in obese non-critically ill patients
- (2014) M Hites et al. Nutrition & Diabetes
- Daptomycin Dosing Based on Ideal Body Weight versus Actual Body Weight: Comparison of Clinical Outcomes
- (2013) Jennifer K. Ng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B Dosing in Obese and Underweight Adults
- (2013) M. P. Pai CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Impact of Weight on Treatment Efficacy and Safety in Complicated Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus
- (2013) Laura A. Puzniak et al. CLINICAL THERAPEUTICS
- Steady-state pharmacokinetics and pharmacodynamics of meropenem in morbidly obese patients hospitalized in an intensive care unit
- (2013) S. Christian Cheatham et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Serum In Vivo and In Vitro Activity of Single Dose of Ertapenem in Surgical Obese Patients for Prevention of SSIs
- (2013) Carlo de Werra et al. OBESITY SURGERY
- Safety and Effectiveness of Daptomycin Across a Hospitalized Obese Population: Results of a Multicenter Investigation in the Southeastern United States
- (2013) P. Brandon Bookstaver et al. PHARMACOTHERAPY
- Performance of a vancomycin dosage regimen developed for obese patients
- (2012) D. C. Reynolds et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Case-Control Study of Drug Monitoring of -Lactams in Obese Critically Ill Patients
- (2012) M. Hites et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with Infections
- (2012) Emil Samara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
- (2012) Timothy P. Gauthier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Steady-state pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese patients
- (2012) S. Christian Cheatham et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comment on: Acute renal insufficiency during telavancin therapy in clinical practice
- (2012) M. P. Pai JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of Various Body Weights and Serum Creatinine Concentrations on the Bias and Accuracy of the Cockcroft-Gault Equation
- (2012) Mary A. Winter et al. PHARMACOTHERAPY
- Effect of Body Mass Index on Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults: Comparison of Ertapenem with Piperacillin-Tazobactam
- (2012) Tanya L. Zakrison et al. Surgical Infections
- Pharmacokinetics and Tissue Penetration of Cefoxitin in Obesity
- (2011) Octavian Toma et al. ANESTHESIA AND ANALGESIA
- Pharmacokinetics of Intravenous Levofloxacin Administered at 750 Milligrams in Obese Adults
- (2011) Aaron M. Cook et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients
- (2011) M. G. Kees et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Estimating the Glomerular Filtration Rate in Obese Adult Patients for Drug Dosing
- (2010) Manjunath P. Pai ADVANCES IN CHRONIC KIDNEY DISEASE
- Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
- (2010) Sujata M. Bhavnani et al. CLINICAL INFECTIOUS DISEASES
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Estimation of creatinine clearance in morbidly obese patients
- (2009) Jasmina A. Demirovic et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program
- (2009) D. A. Figueroa et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis
- (2009) Brett H Heintz et al. PHARMACOTHERAPY
- Continuous Cefazolin Infusion To Treat Bone and Joint Infections: Clinical Efficacy, Feasibility, Safety, and Serum and Bone Concentrations
- (2008) V. Zeller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
- (2008) Alexandre P. Zavascki et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now